3/25/2008

European experts on Monday said that Xenical, Roche Holding's obesity treatment, reduced blood pressure in people with hypertension, unlike its rival Meridia, Abbott Laboratories' appetite suppressant. The findings were from a meta-analysis of published reports that assessed the effects of weight-loss treatments on such patients.

Full Story:
Reuters

Related Summaries